TrialSiteNews

We sit down with Ralph Lorigo, of the Law Office of Ralph C. Lorigo to discuss NY court cases regarding Ivermectin and Covid-19. His firm have represented a number of elderly patients who have taken on their respective hospitals who refused to continue to administer doctor prescribed Ivermectin for the treatment Covid-19. This episode does not discuss the efficacy of the drug in relation to the virus, but rather, the legal fight surrounding it. Watch the video to hear the whole story! Check out the Law Office Of Ralph C. Lorigo | https://www.lorigo.com/

John W. Swanson, an 81-year-old farmer from Stafford, New York, a rural area east of Buffalo, was infected with COVID-19, on a ventilator, and according to a legal affidavit, ‘on death’s doorstep’ at United Memorial Medical Center (part of Rochester Regional Health). The patient was given one dose of ivermectin, and started breathing again. But in what is becoming a similar New York State story, the hospital’s doctors then refused to give follow-up doses of ivermectin. And the patient’s family moved swiftly for justice. Swanson’s wife Sandra hired the same attorneys that were able to convince other New York State judges to compel other hospitals to administer ivermectin to dying patients. Story Article: https://trialsitenews.com/another-new-york-state-supreme-court-justice-ivermectin-order-helping-81-year-old-farmer/ Reminder: We here at TrialSite News always recommend seeking advice from a physician for treatment in regards to Covid-19. Additionally as of the filming of this episode, here in the US the official guidelines from the FDA and the NIH are as follows. First, The FDA has cautioned against its use for Covid-19 saying that they have not approved ivermectin for use in treating or preventing COVID-19 in humans. The FDA also added a notice about the use of the animal version of Ivermectin saying that one should “Never use medications intended for animals on yourself. Ivermectin preparations for animals are very different from those approved for humans.” Second, The NIH has a softer stance on the subject of Ivermectin, with a more neutral stance, neither for, nor against the use of the drug.

Join The Conversation! | https://trialsitenews.com/ Dr. Robert Malone is a physician, researcher, one of the founders of mRNA vaccine technology and is a consultant for biologics and vaccines, bench to bedside.

Join The Conversation! | https://trialsitenews.com/ Dr. Robert Malone is a physician, researcher, one of the founders of mRNA vaccine technology and is a consultant for biologics and vaccines, bench to bedside.

Join The Conversation! | https://trialsitenews.com/ Dr. Audrey Dionne is a cardiologist at Boston Children's Hospital. She did a study on rare post-vaccine condition myocarditis in kids, which was published in JAMA Cardiology. Study Link | https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052?resultClick=1

Join The Conversation! | https://trialsitenews.com/ Dr. Audrey Dionne is a cardiologist at Boston Children's Hospital. She did a study on rare post-vaccine condition myocarditis in kids, which was published in JAMA Cardiology. Study Link | https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052?resultClick=1

Dr. Ron Brown of Waterloo University talks about his Cambridge and Medicina Paper. We discuss relative risk reduction and absolute risk reduction measures in the evaluation of clinical trial data. Dr. Ron Brown discusses the danger of outcome reporting bias. Articles Referenced: Medicina | Free Full-Text | Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials (mdpi.com) Public Health Lessons Learned From Biases in Coronavirus Mortality Overestimation (cambridge.org)

Dr. Janie Shelton PhD, a data scientist from 23andMe, discusses their research on genetic and nongenetic associations with COVID-19 published in Nature Genetics. Links | https://www.nature.com/articles/s41588-021-00854-7#Sec8 23andMe website | https://www.23andme.com/ Vaccine research blog on 23andMe, mentioned in the video | https://blog.23andme.com/23andme-research/covid-19-vaccine-reactions/ Link to study in Nature Genetics | https://www.nature.com/articles/s41588-021-00854-7#Sec8

Dr. Janie Shelton PhD, a data scientist from 23andMe, discusses their research on genetic and nongenetic associations with COVID-19 published in Nature Genetics. Links | https://www.nature.com/articles/s41588-021-00854-7#Sec8 23andMe website | https://www.23andme.com/ Vaccine research blog on 23andMe, mentioned in the video | https://blog.23andme.com/23andme-research/covid-19-vaccine-reactions/ Link to study in Nature Genetics | https://www.nature.com/articles/s41588-021-00854-7#Sec8

An interview with Dr. Tess Lawrie. We discuss the ongoing saga surrounding her meta-analysis on Ivermectin studies for the safety and efficacy against Covid-19. We also touch on the FDA recent announcement cautioning against the use of the drug, and Dr. Andrew Hill. Dr. Lawrie is the director of E-BMC Ltd. and is committed to improving the quality of healthcare through rigorous research. She is a frequent member of technical teams responsible for developing international guidelines. Her peer-reviewed publications have received in excess of 3000 citations and her ResearchGate score is among the top 5% pf ResearchGate members. Website: https://www.e-bmc.co.uk/

In what could be considered problematic implications for COVID-19 vaccination in India, a recent study involving 614 Indian health workers found a “significant” drop in the study participant’s COVID-19-fighting antibodies within a couple of months of the second dose in the case of the COVID-19 vaccine product Covaxin. Of course, more data is needed for a better understanding of these results, but such an outcome may indicate a need for a booster program in the world’s second-most populous nation.

Join The Conversation! | https://trialsitenews.com/ U.S. Poison Control Ivermectin Data Analyzed by TrialSite – Some Surprises he U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and prominent physician and pharmacy societies have stepped up and intensified warnings about the use of ivermectin across mass media. While a recent American Medical Association warning press release cites a huge rise in ivermectin prescriptions and a 3-Fold increase in calls to poison control centers associated with the misuse of the generic drug. Article Link | https://trialsitenews.com/u-s-poison-control-ivermectin-data-analyzed-by-trialsite-some-surprises/

Join The Conversation! | https://trialsitenews.com/ Sweeping Vaccine Mandates Showcase Unprecedented Use of Federal Powers in Modern Era The Biden administration “doubled down” on mandates and other measures based on the premise that pandemic eradication can be accomplished through mass vaccination, and now the president is using his formidable executive powers for sweeping federal vaccine requirements impacting up to 100 million Americans. Link | https://trialsitenews.com/potus-sweeping-vaccine-mandates-showcase-unprecedented-use-of-federal-powers-in-modern-era/

Dr. Travis N. Rieder, PhD, is the Assistant Director for Education Initiatives, Director of the Master of Bioethics degree program and Research Scholar at the Berman Institute of Bioethics. He is also a Faculty Affiliate at the Center for Public Health Advocacy within the Johns Hopkins School of Public Health. While he believes there are plenty of good reasons to get vaccinated, he presents the case for why it isn't someone's ethical duty to do so.

Join The Conversation! | https://trialsitenews.com/ Judge Rules In Favor of a Hospital: Denying Use of Ivermectin For Covid Patient An unvaccinated man lay dying in the hospital as his wife pleaded for Springfield, IL-based Memorial Medical Center to treat the patient, 61-year-old Randy Clouse. On a ventilator for at least four weeks, Mrs. Clouse took legal action against the hospital as they declared administering ivermectin would convert the patient into a “human guinea pig.” Now a county circuit judge, Adam Gigani, denied the request for an injunction against the hospital. Link | https://trialsitenews.com/hospital-wins-against-dying-plaintiff-wife-pleading-for-ivermectin/Vaccine Shakeup at FDA as Key Leadership Resigns, Leaving A Potential Void That Could Impact POTUS Vaccination ProgramMarian Gruber, director of the U.S. Food and Drug Administration (FDA) Vaccine Research Review Bureau, and Phil Krause, deputy director, plan on stepping down this October and November, respectively. The senior Agency executives responsible for reviewing the recent Pfizer COVID-19 vaccine submission are on their way out. Link | https://trialsitenews.com/vaccine-shakeup-at-fda-as-key-leadership-resigns-leaving-a-potential-void-impacting-potus-vaccination-program/

Join The Conversation! | https://trialsitenews.com/ Interview with Ivan Jarry, CEO of ObvioHealth, on Virtual Clinical Trials Links | https://www.obviohealth.com/

Join The Conversation! | https://trialsitenews.com/ An interview with Kelly McKee from Medidata on transforming the patient clinical trial experience. Links | https://www.medidata.com/en

Join The Conversation! | https://trialsitenews.com/ Story 1 | Prominent Indian Physician Talks Impact Of Ivermectin In Home Medicine Kits in India TrialSite News chronicled closely the use of ivermectin-based home medicine kits in India’s largest state, Uttar Pradesh, and other states during the second wave of the pandemic starting in March and running through April. TrialSite News shared that by June cases plummeted to what is today’s far more contained situation. Article Link | https://trialsitenews.com/prominent-indian-physician-verifies-huge-impact-of-ivermectin-in-curbing-second-delta-variant-wave-in-india/ Story 2 | FDA Approves First COVID-19 Vaccine: Why Are they Rushing? The U.S. Food and Drug Administration (FDA) approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals. Article Link | https://trialsitenews.com/fda-approves-first-covid-19-vaccine-why-are-they-rushing/

Join The Conversation! | https://trialsitenews.com/ Dr. Ariel Israel MD, PhD, Head of Leumit Research Institute, discusses the COVID-19 situation in Israel & his research on the vaccine. Dr. Ariel Israel Study links: https://www.medrxiv.org/content/10.1101/2021.08.03.21261496v1.full https://www.medrxiv.org/content/10.1101/2021.08.19.21262111v1 https://elifesciences.org/articles/68165 https://www.medrxiv.org/content/10.1101/2020.09.04.20188268v1 https://elifesciences.org/articles/68165.pdf

Join The Conversation! | https://trialsitenews.com/ Dr. Barry Popkin discusses the Impact of Obesity on COVID-19 with Dr. Erin Stair. Discussed Links: https://onlinelibrary.wiley.com/doi/10.1111/obr.13128 https://sph.unc.edu/sph-news/obesity-is-a-major-risk-factor-for-covid-19-complications/

Join The Conversation! | https://trialsitenews.com/ Story | Australian SuperDome to be Used to Herd 24,000 High Schoolers to Receive Pfizer Vaccine—Told a ‘Golden Opportunity’ 24,000 children will be “ushered” into Sydney’s “Super Dome” also known as “Qudos Bank Arena” for a mass high school student vaccination event. According to an Australian government official, the time is now to get “as many jabs in the arms as possible.” The state government of New South Wales (NSW) was planning on busing the high school students from western and south western suburbs to what they refer to as “mass vaccination hubs,” moving forward with an aggressive program of mass vaccination. Article Link | https://trialsitenews.com/australian-superdome-to-be-used-to-herd-24000-high-schoolers-to-receive-pfizer-vaccine-told-a-golden-opportunity/ Story | Pfizer’s Phase 2/3 ‘COVID Pill Study’ Reveals Potential Antiviral Treatment (PF-07321332) Under Investigation The race is on for the clinical development of the “COVID-19 pill,” an orally administered antiviral medication for early treatment that primary care providers have screamed about for over 1.5 years now. Article Link | https://trialsitenews.com/pfizers-phase-2-3-covid-pill-study-reveals-potential-antiviral-treatment-pf-07321332-under-investigation/

Join The Conversation! | https://trialsitenews.com/ Story 1 | Study Led by Fred Hutch & Emory Investigators Shows SARS-CoV-2 Infected Patients Have Broad, Effective & Possibly Long-Term Immunity A sophisticated team of researchers operating at Fred Hutchinson Cancer Research Center and Emory University suggest that transcending the COVID-19 pandemic necessitates what they refer to as “long-lived immunity to SARS-CoV-2.” Leading a longitudinal study involving 254 COVID-19 patients over an eight-month period, the study team observed what they referred to as “durable broad-based immune responses” in those mild-to-moderate COVID-19 patients. Article Link | https://trialsitenews.com/study-led-by-fred-hutch-emory-investigators-shows-sars-cov-2-infected-patients-have-broad-effective-possibly-long-term-immunity/ Story 2 | Vaccination Crisis or False Alarm in Israel? 90% of COVID-19 Patients Fully Vaccinated Israel led the pandemic as an organized, prepared, and aligned population that accepted an aggressive, methodical, and overall successful effort leading to one of the most vaccinated populations against SARS-CoV-2, the virus behind COVID-19. But with the delta variant came breakthrough infections. That is, individuals who were fully vaccinated became infected anyway. Article Link | https://trialsitenews.com/vaccination-crisis-or-false-alarm-in-israel-90-of-covid-19-patients-fully-vaccinated/

Join The Conversation! | https://trialsitenews.com/ Can Public Universities Require Covid-19 Vaccines? Former Mayor and HealthTech CEO Paul Johnson Weighs in with an interview with Dr. Erin Stair. Related Links: About (redirecthealth.com)

Join The Conversation! | https://trialsitenews.com/ Dr. Maria Mitrani discusses Zofin (Organicell) for Patients With Covid-19 Links | Published case report study- using Zofin on COVID-19 pts: https://www.frontiersin.org/articles/10.3389/fmed.2021.583842/full Website | https://organicell.com/

Join The Conversation! | https://trialsitenews.com/ Article 1 | Fauci Out Selling Early Oral Treatments Now—Seeking to Monetize the Majority of COVID-19 Cases Dr. Anthony Fauci is back in sales mode, now representing his pharmaceutical patrons. After spending many billions already on what in many cases have become throw-away monoclonal antibodies and several questionable therapies in the pipeline, the head of the National Institute of Allergy and Infectious Diseases (NIAID) and chief medical advisor to POTUS spent lots of time minimizing the mounting evidence associated with many generic early COVID-19 treatment options, from fluvoxamine and ivermectin to even hydroxychloroquine used in select scenarios. Now Fauci will deliver to the market the perfect pill and help the industry monetize the massive market for early-onset COVID-19 mild-to-moderate cases—the 90%+ of total cases that fit in that category. Link | https://trialsitenews.com/fauci-out-selling-early-oral-treatments-now-seeking-to-monetize-the-majority-of-covid-19-cases/ Reuters YouTube Video Link | https://www.youtube.com/watch?v=dkMhqswIc20&t=107s\ Article 2 | Move to Quiet Doctors with Risk of Pulling Medical Licenses Over ‘Misinformation’ The stakes against purported “misinformation” get even more controversial as the Federation of State Medical Boards’ Board of Directors released a statement declaring that physicians and other health care professionals involved in the dissemination of COVID-19 vaccine misinformation and disinformation via social media platforms, online and in the media, face grave potential actions, including the loss of medical license. Link | https://trialsitenews.com/move-to-quiet-doctors-with-risk-of-pulling-medical-licenses-over-misinformation/